B Finkel
Overview
Explore the profile of B Finkel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ambrosch F, Finkel B, Herzog C, Koren A, Kollaritsch H
Infection
. 2004 Jun;
32(3):149-52.
PMID: 15188074
Background: This study was designed to assess the early antibody kinetics after a priming dose, and the extent of the antibody increase after a booster dose of an inactivated virosomal...
2.
Segman R, Goltser T, Heresco-Levy U, Finkel B, Shalem R, Schlafman M, et al.
Pharmacogenomics J
. 2003 Oct;
3(5):277-83.
PMID: 14583797
Tardive dyskinesia (TD) is a long-term adverse effect of antipsychotic drugs that are dopamine D2 receptor blockers. Serotonin receptor antagonism has been proposed as a common mechanism contributing to the...
3.
Frisch A, Finkel B, Michaelovsky E, Sigal M, Laor N, Weizman R
Psychiatr Genet
. 2001 Apr;
10(4):179-83.
PMID: 11324943
The serotonin transporter gene (SLC6A4), which plays a key role in the serotonergic pathway in the brain, is a candidate for mediating genetic susceptibility to various psychiatric disorders. There are...
4.
Segman R, Heresco-Levy U, Finkel B, Goltser T, Shalem R, Schlafman M, et al.
Mol Psychiatry
. 2001 Apr;
6(2):225-9.
PMID: 11317227
Tardive dyskinesia (TD) is a long-term adverse effect of antipsychotic drugs that are dopamine D2 receptor blockers.(1) Serotonin receptor antagonism has been proposed as a common mechanism contributing to the...
5.
Kodesh A, Katz S, Lerner A, Finkel B, Sigal M
J Psychopharmacol
. 2001 Mar;
15(1):58-60.
PMID: 11277610
Three outpatients who fulfilled full DSM-IV diagnostic criteria for premenstrual dysphoric disorder (PDD) were successfully treated with intermittent (luteal phase) nefazodone. They received the medication at low doses of up...
6.
Kodesh A, Finkel B, Lerner A, Kretzmer G, Sigal M
Int Clin Psychopharmacol
. 2001 Mar;
16(2):117-9.
PMID: 11236070
Leukopenia and agranulocytosis are well reported and dangerous haematological side-effects associated with the use of typical and atypical antipsychotics. These potentially life-threatening phenomena have led to treatment discontinuation and the...
7.
Segman R, Heresco-Levy U, Finkel B, Inbar R, Neeman T, Schlafman M, et al.
Psychopharmacology (Berl)
. 2001 Jan;
152(4):408-13.
PMID: 11140333
Rationale: Tardive dyskinesia (TD) is a longterm adverse effect of dopamine receptor blockers. The dopamine D3 receptor gene (DRD3) ser9gly polymorphism has been previously associated with susceptibility to TD. Serotonin...
8.
Lerner A, Gelkopf M, Oyffe I, Finkel B, Katz S, Sigal M, et al.
Int Clin Psychopharmacol
. 2000 Jun;
15(1):35-7.
PMID: 10836284
A pilot open study was conducted in order to evaluate the efficacy of clonidine in the treatment of LSD-induced hallucinogen persisting perception disorder (HPPD). Eight patients fulfilled entrance criteria. All...
9.
Gole M, Souza J, Choi I, Hertkorn C, Malcolm S, Foust 3rd R, et al.
Am J Physiol Lung Cell Mol Physiol
. 2000 Apr;
278(5):L961-7.
PMID: 10781426
The present study identifies proteins modified by nitration in the plasma of patients with ongoing acute respiratory distress syndrome (ARDS). The proteins modified by nitration in ARDS were revealed by...
10.
Segman R, Neeman T, Heresco-Levy U, Finkel B, Karagichev L, Schlafman M, et al.
Mol Psychiatry
. 1999 Jul;
4(3):247-53.
PMID: 10395214
Dopamine receptor antagonism is a common mechanism underlying the therapeutic efficacy of all classical antipsychotic drugs. It is also thought to underlie the propensity of these agents to induce the...